{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:43:07Z","timestamp":1761061387642},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The value of bladder cancer (BC) substaging into macroscopic (pT3b) and microscopic (pT3a) perivesical fat extension in lymph node (Ln)-negative patients is controversially discussed and limited evidence for prognostic relevance of additional histopathological factors in pT3 BC exists. We evaluated the prognostic value of pT3 substaging and established pathological and clinical parameters with focus on tumor invasive front (TIF) and tumor size.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Specimens of 52 patients treated with radical cystectomy (RC) for pT3 a\/b muscle-invasive BC were reviewed and re-evaluated by a pathologist specialized in uropathology. Clinical variables and standard histopathologic characteristics were assessed including TIF and tumor size. Their value as prognosticators for overall survival (OS) and recurrence-free survival (RFS) was evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mean age of patients was 67.55\u00a0years. Tumors were staged pT3a in 28 patients (53.8%) and pT3b in 24 (46.8%). Median OS was 34.51\u00a0months. Median tumor size was 3.2\u00a0cm, median TIF was 11.0\u00a0mm. Differences in OS between pT3a and pT3b were not significant (<jats:italic>p<\/jats:italic>\u2009=\u20090.45). Carcinoma in situ (CIS) and lymphovascular invasion (LVI) were significantly associated with pT3b tumors. Univariate analysis could not identify pathological prognosticators like TIF or tumor size for OS and RFS (<jats:italic>p<\/jats:italic> for all\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>No significant differences in OS or RFS were observed comparing Ln-negative pT3 BC following radical cystectomy. Additional pathologic variables like TIF could not be identified as prognosticator. Relevance of pT3 BC substaging needs reevaluation in larger prospective cohorts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-021-03697-3","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T04:04:25Z","timestamp":1618977865000},"page":"4021-4027","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?"],"prefix":"10.1007","volume":"39","author":[{"given":"Moritz","family":"Maas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Mischinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Comp\u00e9rat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Scharpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Todenh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Gakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"issue":"1","key":"3697_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics. CA A Cancer J Clin 69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551","journal-title":"CA A Cancer J Clin"},{"key":"3697_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.03.055","author":"JA Witjes","year":"2020","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comp\u00e9rat EM, Cowan NC, Gakis G, Hern\u00e1ndez V, Linares Espin\u00f3s E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskim\u00e4e E, Ribal MJ, van der Heijden AG (2020) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2020 guidelines. EurUrol. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.055","journal-title":"EurUrol"},{"issue":"4","key":"3697_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.urology.2010.02.073","volume":"76","author":"E Scosyrev","year":"2010","unstructured":"Scosyrev E, Yao J, Messing E (2010) Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice. Urology 76(4):908\u2013913. https:\/\/doi.org\/10.1016\/j.urology.2010.02.073 (Discussion 914)","journal-title":"Urology"},{"issue":"3","key":"3697_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/pap.0000000000000152","volume":"24","author":"GP Paner","year":"2017","unstructured":"Paner GP, Montironi R, Amin MB (2017) Challenges in pathologic staging of bladder cancer: proposals for fresh approaches of assessing pathologic stage in light of recent studies and observations pertaining to bladder histoanatomic variances. AdvAnatPathol 24(3):113\u2013127. https:\/\/doi.org\/10.1097\/pap.0000000000000152","journal-title":"AdvAnatPathol"},{"issue":"5","key":"3697_CR5","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.juro.2012.07.035","volume":"188","author":"S Zarei","year":"2012","unstructured":"Zarei S, Frank I, Boorjian SA, Thompson RH, Kim S, Weight C, Tarrell R, Thapa P, Cheville JC (2012) Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications. J Urol 188(5):1706\u20131711. https:\/\/doi.org\/10.1016\/j.juro.2012.07.035","journal-title":"J Urol"},{"issue":"3","key":"3697_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.urology.2007.12.061","volume":"72","author":"K Matsumoto","year":"2008","unstructured":"Matsumoto K, Soh S, Satoh T, Iwamura M, Ishikawa Y, Ishii T, Baba S (2008) Distribution of lymphatic vessel network in normal urinary bladder. Urology 72(3):706\u2013710. https:\/\/doi.org\/10.1016\/j.urology.2007.12.061","journal-title":"Urology"},{"issue":"3","key":"3697_CR7","first-page":"118","volume":"29","author":"C Marchetti","year":"1996","unstructured":"Marchetti C, Poggi P, Farina A, Gritti A, Scelsi L, Scelsi R (1996) Structure of the initial lymphatics of the human urinary bladder with invasive urothelial tumors. Lymphology 29(3):118\u2013125","journal-title":"Lymphology"},{"issue":"2","key":"3697_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.juro.2010.04.007","volume":"184","author":"D Tilki","year":"2010","unstructured":"Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Sonpavde G, Gupta A, Kassouf W, Fradet Y, Ficarra V, Skinner E, Lotan Y, Sagalowsky AI, Stief CG, Reich O, Shariat SF (2010) pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. J Urol 184(2):470\u2013474. https:\/\/doi.org\/10.1016\/j.juro.2010.04.007","journal-title":"J Urol"},{"issue":"11","key":"3697_CR9","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/j.1464-410X.2012.11104.x","volume":"110","author":"Y Neuzillet","year":"2012","unstructured":"Neuzillet Y, Lebret T, Molinie V, Yonneau L, Herve JM, Theodore C, Botto H (2012) Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications. BJU Int 110(11):1736\u20131741. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11104.x","journal-title":"BJU Int"},{"key":"3697_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/1471-2407-11-336","volume":"11","author":"P Msaouel","year":"2011","unstructured":"Msaouel P, Koutsilieris M (2011) Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis. BMC Cancer 11:336. https:\/\/doi.org\/10.1186\/1471-2407-11-336","journal-title":"BMC Cancer"},{"issue":"4","key":"3697_CR11","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.juro.2010.11.082","volume":"185","author":"G Sonpavde","year":"2011","unstructured":"Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF (2011) Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. J Urol 185(4):1216\u20131221. https:\/\/doi.org\/10.1016\/j.juro.2010.11.082","journal-title":"J Urol"},{"issue":"4","key":"3697_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/cncr.24110","volume":"115","author":"KJ Boudreaux Jr","year":"2009","unstructured":"Boudreaux KJ Jr, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA Jr, Clark PE (2009) Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer 115(4):770\u2013775. https:\/\/doi.org\/10.1002\/cncr.24110","journal-title":"Cancer"},{"issue":"2","key":"3697_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11255-013-0381-7","volume":"45","author":"C Dincel","year":"2013","unstructured":"Dincel C, Kara C, Balci U, Ozer K, Ozbir S, Sefik E, Gorgel SN, Girgin C (2013) Comparison of microscopic (pT3a) and gross extravesical extension (pT3b) in pathological staging of bladder cancer: analysis of patient outcomes. Int Urol Nephrol 45(2):387\u2013393. https:\/\/doi.org\/10.1007\/s11255-013-0381-7","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"3697_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.7150\/jca.12259","volume":"6","author":"HS Kim","year":"2015","unstructured":"Kim HS, Piao S, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH (2015) Adjuvant chemotherapy correlates with improved survival after radical cystectomy in patients with pT3b (macroscopic perivesical tissue invasion) bladder cancer. J Cancer 6(8):750\u2013758. https:\/\/doi.org\/10.7150\/jca.12259","journal-title":"J Cancer"},{"issue":"2","key":"3697_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/01.ju.0000108664.39035.51","volume":"171","author":"ML Quek","year":"2004","unstructured":"Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Cote RJ, Lieskovsky G, Quinn DI, Skinner DG (2004) Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol 171(2):640\u2013645. https:\/\/doi.org\/10.1097\/01.ju.0000108664.39035.51","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-021-03697-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-021-03697-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-021-03697-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T15:03:04Z","timestamp":1636124584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-021-03697-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3697"],"URL":"https:\/\/doi.org\/10.1007\/s00345-021-03697-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"1 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant conflict of interest in the context of the work presented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\/competing interests"}},{"value":"The study was approved by the Ethics Committee of the University of T\u00fcbingen (APPROVAL number: 417\/2010\u2009A).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent to participate was given by the patients or their legal representatives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}